companies developing glp-1 drugs Chinese Are Advanced Middle East & Africa Glucagon-like
Description
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and the treatment of type 2 diabetes
But the other drugs bring their own side effects
GIP, another type of incretin, contributes to improving white adipose tissue function by increasing fat storage and reducing visceral ectopic deposition
Originally developed for type 2 diabetes, semaglutide has gained significant recognition for its powerful effectiveness in promoting safe and sustainable weight loss
Ongoing and future largescale randomized trials will be critical for clarifying efficacy and safety for this use
